首页> 外国专利> benzimidazolin - 2 - oxo - 1 - carboxylic acid derivatives, usable as antagonists of 5-ht receptors.

benzimidazolin - 2 - oxo - 1 - carboxylic acid derivatives, usable as antagonists of 5-ht receptors.

机译:苯并咪唑啉-2-氧代-1-羧酸衍生物,可用作5-ht受体的拮抗剂。

摘要

New pharmacologically active benzimidazoline-2-oxo-1-carboxylic acid derivatives which are 5-HT receptor antagonists useful as antiemetic agents and as gastric prokinetic agents of the following formula: CHEM wherein R represents a hydrogen atom, C1-6 alkyl, C1-6 alkenyl or C1-6 alkynil; R1 and R2 may be at the same time or not a hydrogen atom, halogen, trifluoromethyl, C1-6 alkyl, C1-6 alkoxy, C1-6 alkylthio, C1-6 acyl, carboxyl, C1-6 alkoxycarbonyl, hydroxy, nitro, amino optionally C1-4 alkyl N-mono or di-substituted, C1-6 acylamino, C1-6 alkoxycarbonylamino, carbamoyl optionally C1-4 alkyl N-mono or di-substituted, cyano, C1-6alkylsulphinyl, C1-6 alkylsulphonyl, amino sulphonyl optionally C1-4 alkyl N-mono or di-substituted, C1-4 alkyl N-mono or di-substituted aminosulphonylamino, aminosulphonylamino; Y is oxygen or is N - R3 in which R3 is a hydrogen, a C1-6 alkyl or optionally substituted by one or more C1-6 alkoxy benzyl; A is a group selected from: CHEM wherein p is 0, 1; r is 0, 1, 2, 3; R4 is hydrogen atom or a C1-4 alkyl; R5 is a hydrogen atom, C1-6 alkyl, C3-8 cycloalkyl, C3-8 cycloalkyl C1-4 alkyl,substituted phenyl C1-4 alkyl or R5 is a group of formula CHEM wherein R6 is hydrogen atom, C1-4 alkyl or an amino group and R7 is hydrogen atom or C1-6 alkyl, tautomers thereof and acid addition salts of the aforesaid compounds. The processes for the preparation of the compounds of formula (I) as well as pharmaceutical compositions containing them are also described.
机译:新的药理活性苯并咪唑啉-2-氧代-1-羧酸衍生物,是5-HT受体拮抗剂,可用作下式止吐药和胃动力药,其化学式如下:其中R代表氢原子,C1-6烷基, C 1-6烯基或C 1-6炔基; R1和R2可以同时或不同时为氢原子,卤素,三氟甲基,C1-6烷基,C1-6烷氧基,C1-6烷硫基,C1-6酰基,羧基,C1-6烷氧基羰基,羟基,硝基,氨基,任选为C 1-4烷基N-单或双取代的氨基,C 1-6酰基氨基,C 1-6烷氧羰基氨基,氨基甲酰基,可选为C 1-4烷基N-单或双取代的氨基,氰基,C 1-6烷基亚磺酰基,C 1-6烷基磺酰基,氨基磺酰基任选地为C 1-4烷基N-单或二取代的磺酰基,C 1-4烷基N-单或二取代的氨基磺酰基氨基,氨基磺酰基氨基; Y为氧或为N-R3,其中R3为氢,C1-6烷基或任选地被一个或多个C1-6烷氧基苄基取代; A为选自以下的基团:<化学式>其中p为0、1; r为0、1、2、3; R 4为氢原子或碳数1〜4的烷基。 R 5是氢原子,C 1-6烷基,C 3-8环烷基,C 3-8环烷基C 1-4烷基,取代的苯基C 1-4烷基或R 5是式的基团,其中R 6是氢原子,C 1-4 R7为氢原子或C1-6烷基,其互变异构体和上述化合物的酸加成盐。还描述了制备式(I)化合物的方法以及包含它们的药物组合物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号